Utilization of CELL PICKER and MCE-202 MultiNA in the eld of genome editing
Technical notes | 2019 | ShimadzuInstrumentation
Genome editing via CRISPR/Cas9 and related nucleases has revolutionized genetic modification by enabling targeted, efficient alterations in diverse organisms. Automating labor-intensive steps like colony picking and mutation confirmation addresses throughput and reproducibility challenges in research and industrial settings.
This work demonstrates the integration of Shimadzu's CELL PICKER and MCE-202 MultiNA systems into a genome editing workflow to enhance the efficiency of isolating and verifying clones carrying desired edits. The focus is on automating colony separation and confirming mutations to accelerate downstream analysis.
The standard genome editing workflow comprises six stages: gene modification (via CRISPR/Cas9 or other nucleases), clone isolation by colony separation or limiting dilution, culture expansion, mutation confirmation, gene verification, and final clone recovery. CELL PICKER automates stage two (colony separation) by selecting and transferring individual colonies under microscope control. MCE-202 MultiNA implements heteroduplex mobility assays at stage four, using microchip electrophoresis to detect insertions or deletions by differences in DNA strand migration.
In benchmarking, CELL PICKER reduced the total time for picking 48 colonies by over 50%, maintaining a consistent rate of under two minutes per colony compared to manual methods. Time-lapse imaging and immunostaining of picked iPS cell colonies confirmed normal proliferation and retention of pluripotency markers post-picking. The MCE-202 MultiNA heteroduplex mobility assay produced clear, reproducible patterns distinguishing wild-type, mutant, and heteroduplex DNA species, facilitating rapid pre-screening of edited clones before sequencing.
Advances may include integration with machine learning–driven colony selection, coupling with high-content imaging for phenotypic screening, adaptation to single-cell editing platforms, and incorporation into automated end-to-end genome engineering pipelines for precision medicine and industrial biotechnology.
The combined use of CELL PICKER and MCE-202 MultiNA significantly streamlines the post-editing workflow by automating colony picking and delivering rapid, reliable mutation screening. This integrated solution enhances efficiency, consistency, and scalability in generating validated genome-edited cell lines.
Microscopy, Capillary electrophoresis
IndustriesPharma & Biopharma, Clinical Research
ManufacturerShimadzu
Summary
Significance of the Topic
Genome editing via CRISPR/Cas9 and related nucleases has revolutionized genetic modification by enabling targeted, efficient alterations in diverse organisms. Automating labor-intensive steps like colony picking and mutation confirmation addresses throughput and reproducibility challenges in research and industrial settings.
Objectives and Overview of the Study
This work demonstrates the integration of Shimadzu's CELL PICKER and MCE-202 MultiNA systems into a genome editing workflow to enhance the efficiency of isolating and verifying clones carrying desired edits. The focus is on automating colony separation and confirming mutations to accelerate downstream analysis.
Methodology and Instrumentation
The standard genome editing workflow comprises six stages: gene modification (via CRISPR/Cas9 or other nucleases), clone isolation by colony separation or limiting dilution, culture expansion, mutation confirmation, gene verification, and final clone recovery. CELL PICKER automates stage two (colony separation) by selecting and transferring individual colonies under microscope control. MCE-202 MultiNA implements heteroduplex mobility assays at stage four, using microchip electrophoresis to detect insertions or deletions by differences in DNA strand migration.
Instrumentation Used
- CELL PICKER: automated colony picking tool with pipetting unit, integrated microscope, and camera.
- MCE-202 MultiNA: fully automated DNA/RNA microchip electrophoresis system enabling high-throughput sizing and quantification.
Main Results and Discussion
In benchmarking, CELL PICKER reduced the total time for picking 48 colonies by over 50%, maintaining a consistent rate of under two minutes per colony compared to manual methods. Time-lapse imaging and immunostaining of picked iPS cell colonies confirmed normal proliferation and retention of pluripotency markers post-picking. The MCE-202 MultiNA heteroduplex mobility assay produced clear, reproducible patterns distinguishing wild-type, mutant, and heteroduplex DNA species, facilitating rapid pre-screening of edited clones before sequencing.
Benefits and Practical Applications of the Method
- Enhanced throughput and reproducibility in clone isolation.
- Reduced operator variability and skill dependency.
- Cost-effective mutation pre-screening to prioritize samples for sequencing.
- Wide applicability in academic research, biopharmaceutical development, quality control, and synthetic biology.
Future Trends and Potential Applications
Advances may include integration with machine learning–driven colony selection, coupling with high-content imaging for phenotypic screening, adaptation to single-cell editing platforms, and incorporation into automated end-to-end genome engineering pipelines for precision medicine and industrial biotechnology.
Conclusion
The combined use of CELL PICKER and MCE-202 MultiNA significantly streamlines the post-editing workflow by automating colony picking and delivering rapid, reliable mutation screening. This integrated solution enhances efficiency, consistency, and scalability in generating validated genome-edited cell lines.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
MultiNA II MCE-301 Microchip Electrophoresis System
2026|Shimadzu|Brochures and specifications
C297-E157 Microchip Electrophoresis System MultiNA II MCE-301 Unlock the Potential MultiNA II ™ Simple and Smart Workflow User-Friendly Design Expandable Application Range Simple and Smart Workflow Designed with the user in mind, MultiNA II enables efficient, reliable analysis using simple…
Key words
tuna, tunabigeye, bigeyeyellowfin, yellowfinbluefin, bluefinpcr, pcrmultina, multinameat, meatmicrochip, microchipsouthern, southernanalysis, analysisrna, rnasize, sizesamples, sampleselectrophoresis, electrophoresisngs
Guide to Biopharmaceutical Solutions — From Cell Line Optimization to Pharmacokinetics —
2021|Shimadzu|Guides
C10G-E089 Guide to Biopharmaceutical Solutions —From Cell Line Optimization to Pharmacokinetics— Solutions Designed for Biopharmaceutical Workflows Optimization DNA/RNA Analysis P. 8–9 P. 4–7 Analysis of Metal Elements in Culture Solutions P. 12–13 Colony Picking Analysis of Chemical Components in Culture…
Key words
culture, cultureindex, indexpharmacokinetics, pharmacokineticscell, cellmouse, mousecharacterization, characterizationothers, otherspurification, purificationcontrol, controlquality, qualityoptimization, optimizationmeasurement, measurementanalysis, analysisprinciple, principleoperating
Guide to Biopharmaceutical Solutions —From Cell Line Optimization to Pharmacokinetics—
2021|Shimadzu|Brochures and specifications
C10G-E089 Guide to Biopharmaceutical Solutions —From Cell Line Optimization to Pharmacokinetics— Solutions Designed for Biopharmaceutical Workflows Optimization DNA/RNA Analysis P. 8–9 P. 4–7 Analysis of Metal Elements in Culture Solutions P. 12–13 Colony Picking Analysis of Chemical Components in Culture…
Key words
culture, culturepharmacokinetics, pharmacokineticsindex, indexcell, cellmouse, mousecharacterization, characterizationothers, otherspurification, purificationcontrol, controlquality, qualityoptimization, optimizationmeasurement, measurementanalysis, analysisprinciple, principleoperating
Gene Therapy and Oligonucleotide Compendium - Volume 1
2020|SCIEX|Guides
Gene Therapy and Oligonucleotide Compendium Volume 1 Gene Therapy and Oligonucleotide Compendium Contents Introduction 4 Growing trends and emerging technologies for oligonucleotide and gene therapies 6 The global gene therapy & oligonucleotide market 8 Regional landscape North America EMEAI (Europe,…
Key words
gene, genetherapy, therapyoligonucleotide, oligonucleotidesciex, sciexcompendium, compendiumcontents, contentsdownload, downloadgexp, gexptechnical, technicalexpression, expressionprimer, primerdna, dnaplasmid, plasmidnote, notesnp